Cédric Chauvierre

Dr. Cédric Chauvierre

Laboratory for Vascular Translational Science INSERM U1148 - Université de Paris, F-75018 Paris, France
orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2018 in Biomaterials
Verified
Journal Article
Closed access
MJMaya Juenet
Maya Juenet
RARachida Aid-Launais
Rachida Aid-Launais
BLBo Li
Bo Li
ABAlice Berger
Alice Berger
JAJoël Aerts
Joël Aerts
Cédric ChauvierreCédric Chauvierre
Cédric Chauvierre

1 November 2020 in Biomaterials
Verified
Journal Article
Closed access
AZAlina Zenych
Alina Zenych
LFLouise Fournier
Louise Fournier
Cédric ChauvierreCédric Chauvierre
Cédric Chauvierre

1 August 2005 in Biomaterials
Verified
Journal Article
Closed access
DLDenis Labarre
Denis Labarre
CVChristine Vauthier
Christine Vauthier
Cédric ChauvierreCédric Chauvierre
Cédric Chauvierre
BPBoris Petri
Boris Petri
RMRainer Müller
Rainer Müller
MCMohamed M. Chehimi
Mohamed M. Chehimi

29 July 2016 in Marine Drugs
Verified
Journal Article
Open access
PDF file
LCLucas Chollet
Lucas Chollet
PSPierre Saboural
Pierre Saboural
Cédric ChauvierreCédric Chauvierre
Cédric Chauvierre
JVJean-Noël Villemin
Jean-Noël Villemin
Didier LetourneurDidier Letourneur
Didier Letourneur
Frederic ChaubetFrederic Chaubet
Frederic Chaubet
Fucoidans are widespread cost-effective sulfated marine polysaccharides which have raised interest in the scientific community over last decades for their wide spectrum of bioactivities. Unsurprisingly, nanomedicine has grasped these compounds to develop innovative therapeutic and diagnostic nanosystems. The applications of fucoidans in nanomedicine as imaging agents, drug carriers or for their intrinsic properties are reviewed here after a short presentation of the main structural data and biological properties of fucoidans. The origin and the physicochemical specifications of fucoidans are summarized in order to discuss the strategy of fucoidan-containing nanosystems in Human health. Currently, there is a need for reproducible, well characterized fucoidan fractions to ensure significant progress.

1 November 2003 in Pharmaceutical Research
Verified
Journal Article
Closed access
PDF file
Cédric ChauvierreCédric Chauvierre
Cédric Chauvierre
DLDenis Labarre
Denis Labarre
PCPatrick Couvreur
Patrick Couvreur
CVChristine Vauthier
Christine Vauthier

25 January 2023 in Biomaterials
Verified
Journal Article
Closed access
LFLouise Fournier
Louise Fournier
TTThibault de La Taille
Thibault de La Taille
Cédric ChauvierreCédric Chauvierre
Cédric Chauvierre